- জেনেরিক নাম
- Zafirlukast
- শক্তি
- 20 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Renata PLC.
৳ ২৫.৪৮ ৳ ২৬ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
বাংলাদেশে Zaft 20 mg Tablet ট্যাবলেট হিসেবে পাওয়া যায়; এতে Zafirlukast আছে (২০ mg)। দাম: প্রতি ইউনিট ২৬ টাকা। Zafirlukast-এর অন্য ব্র্যান্ডগুলো এই পাতায় কম দাম থেকে সাজানো আছে, দাম তুলনা করতে পারবেন। এই ব্র্যান্ডের প্রস্তুতকারক Renata PLC। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Zafirlukast-এর ৪টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত। এর চেয়ে কম ইউনিট দামের ব্র্যান্ড আছে ১টি। সবচেয়ে কম দাম Zafir 20 mg Tablet-এর, প্রতি ইউনিট ৳ ২০.০৭।
Zaft 20 mg tablet is made by Renata PLC. and contains zafirlukast, a leukotriene receptor antagonist. It is prescribed for the prevention and long-term treatment of asthma in adults and children aged five years and older. It belongs to a group of medicines that block certain substances in the body involved in airway swelling and tightening. Zaft is taken regularly, including when symptoms are absent, as part of an asthma management plan. The dose and course are decided by the doctor. This medicine does not reverse sudden breathing difficulty, so ask your doctor what to do during an asthma attack.
Zaft is used for the prophylaxis and chronic treatment of asthma in adults and children aged five years and older. It is part of ongoing asthma management and is taken regularly, even during symptom-free periods. It is not intended to reverse bronchospasm in an acute asthma attack. The doctor will decide whether it suits your condition.
Take Zaft exactly as the doctor prescribes; the dose and course are decided by the doctor. The tablet should be taken continuously to achieve benefit, including when you feel well. Food may reduce how much of the medicine the body absorbs, so ask your doctor or pharmacist about the right timing. Do not stop or change the schedule on your own. If you miss a dose, ask your doctor or pharmacist for advice.
In clinical trials, headache and stomach upset such as nausea, vomiting, diarrhoea and abdominal pain were reported with zafirlukast. These are usually mild and do not require stopping therapy. Bruising, bleeding disorders including heavy periods, low platelets and a fall in certain white blood cells have been reported after marketing. Tell your doctor about any unusual bleeding or bruising. Ask your doctor or pharmacist about any reaction that worries you.
Zaft is not for everyone. It should not be given to people with a history of moderate or severe kidney problems, liver impairment or cirrhosis, or allergy to any ingredient, and it is contraindicated in children under seven years. The safety of zafirlukast in human pregnancy has not been established; it is used in pregnancy only if clearly needed, and it should not be given to nursing mothers because it passes into breast milk. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding. Ask your doctor first if you have kidney or liver disease, take warfarin, or have other health conditions.
The safety of zafirlukast in human pregnancy has not been established. It should be used in pregnancy only if clearly needed. It passes into breast milk, so it should not be given to nursing mothers. Tell your doctor if you are pregnant, planning pregnancy or breastfeeding so they can advise you.
Zaft is a leukotriene receptor antagonist. It is used for the prevention and chronic treatment of asthma in adults and children aged five years and older. It is taken regularly as part of an asthma management plan and is not meant to relieve a sudden asthma attack.
Zafirlukast is the generic name of the active ingredient in Zaft. It belongs to the leukotriene receptor antagonist group. These medicines block leukotrienes, substances in the body that contribute to airway swelling and tightening in asthma. The doctor decides how it fits into your treatment.
No. Zaft is not indicated for reversing bronchospasm in an acute asthma attack. It is taken regularly for long-term asthma control. Ask your doctor what to do and which medicine to use if you have sudden breathing difficulty. Do not rely on Zaft for quick relief.
৳ ২৫.৪৮ ৳ ২৬ ২% ছাড় প্রতি ইউনিট
দাম হালনাগাদ: ১৬ Nov ২০২৬
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Zafirlukast is indicated for the prophylaxis and chronic treatment of asthma in adults and children 5 years of age and older.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Zafirlukast is a selective and competitive leukotriene-receptor antagonist (LTRA) of leukotriene D4 and E4 (LTD4 and LTE4), components of slow-reacting substance of anaphylaxis (SRSA). Cysteinyl leukotriene production and receptor occupation have been correlated with the pathophysiology of asthma, including airway oedema, smooth muscle constriction, and altered cellular activity associated with the inflammatory process, which contribute to the signs and symptoms of asthma.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Zafirlukast should be taken continuously.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Zafirlukast may be administered with other therapies routinely used in the management of asthma and allergy. Inhaled steroids, inhaled and oral bronchodilator therapy, antibiotics and antihistamines are examples of agents which have been co-administered with Zafirlukast without adverse interaction.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Zafirlukast should not be given to patients who have previously experienced hypersensitivity to the product or any of its ingredients. Zafirlukast is contraindicated in patients with a history of moderate or severe renal impairment. Zafirlukast is contraindicated in patients with hepatic impairment or cirrhosis; it has not been studied in patients with hepatitis or in long term studies of patients with cirrhosis. Zafirlukast is contraindicated in children under 7 years of age until safety information is available.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Effect on ability to drive or operate machinery: There is no evidence that Zafirlukast affects the ability to drive and use machinery. Administration of Zafirlukast in clinical trials against placebo has been associated with headache (9.9% vs. 9.0%) or gastrointestinal disturbance (nausea 2.6% vs. 2.2%, vomiting 1.2% vs. 1.0%, diarrhoea 2.3% vs. 1.8%, abdominal pain 1.6% vs. 1.2%). These symptoms are usually mild and do not necessitate withdrawal from therapy. During post-marketing experience, bruising, bleeding disorders, including menorrhagia (rare), thrombocytopaenia and agranulocytosis (very rare) have also been reported.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Pregnancy: The safety of Zafirlukast in human pregnancy has not been established. In animal studies, Zafirlukast did not have any apparent effect on fertility and did not appear to have any teratogenic or selective toxic effect on the foetus. The potential risks should be weighed against the benefits of continuing therapy during pregnancy and Zafirlukast should be used during pregnancy only if clearly needed.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Zafirlukast should be taken regularly to achieve benefit, even during symptom free periods. Zafirlukast therapy should normally be continued during acute exacerbations of asthma. Zafirlukast does not allow a reduction in existing steroid treatment. As with inhaled steroids and hormones (disodium cromoglycate, nedocromil sodium), Zafirlukast is not indicated for use in the reversal of bronchospasm in acute asthma attacks. Zafirlukast has not been evaluated in the treatment of labile (brittle) or unstable asthma.এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store between 20-25° C. Protect from light and moisture.একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।